Craft

Nutriband

Stock Price

$6.3

2024-10-29

Market Capitalization

$70.5 M

2024-10-29

Revenue

$2 M

FY, 2026

Nutriband Summary

Company Summary

Overview
Nutriband is a company developing transdermal technology for delivering drugs. It offers an abuse-deterrent fentanyl transdermal system for use in managing chronic pain requiring around-the-clock opioid therapy combined with a proprietary AVERSA technology. The products are used for chronic pain (Aversa Tech), type two diabetes (Novel Transdermal), for motion sickness (Generic Transdermal) treatment.
Type
Public
Status
Active
Founded
2016
HQ
Orlando, FL, US | view all locations
Website
https://nutriband.com/
Cybersecurity rating
Sectors

Key People

  • Gareth Sheridan

    Gareth Sheridan, Founder and CEO

  • Jeff Patrick
  • Alan Smith

    Alan Smith, President 4P Therapeutics

  • Gerald Goodman

    Gerald Goodman, CFO

    LocationsView all

    1 location detected

    • Orlando, FL HQ

      United States

      189 S Orange Ave, Suite 1500

    Nutriband Financials

    Summary Financials

    Revenue (FY, 2026)
    $2.0M
    Gross profit (FY, 2026)
    $566.3K
    Cash (FY, 2026)
    $4.6M
    Enterprise value
    $66.1M

    Footer menu